PRA Health Sciences, Inc. provided earnings guidance for the fiscal 2019. The company is maintaining its 2019 revenue guidance between $3.02 billion and $3.10 billion, representing as reported growth of 5% to 8% and constant currency growth of 6% to 8%. The company is updating GAAP net income per diluted share to between $3.58 and $3.64.